• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本外国游客适当价格计算方法及医疗费用的初步考察。

Preliminary Examination of an Appropriate Price Calculation Method and Medical Treatment Costs for Foreign Visitors in Japan.

作者信息

Takura Tomoyuki

机构信息

Department of Healthcare Economics and Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.

出版信息

Int J Environ Res Public Health. 2021 May 29;18(11):5837. doi: 10.3390/ijerph18115837.

DOI:10.3390/ijerph18115837
PMID:34072299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8199040/
Abstract

This study proposes a method for calculating the appropriate medical treatment price level for foreign visitors (FVs) in Japan. Hospital management costs and foreign prices were analyzed from a market principles perspective to determine the medical treatment price. The study involved two stages: a preliminary survey and an extended survey, supplemented by an international survey. Relatively frequent diseases were selected, and the costs incurred by hospitals for the treatment of FVs were analyzed though data from three hospitals, covering 24 outpatients and 4 inpatients. Payments made by three insurance companies for overseas medical institution services for Japanese tourists with pharyngitis were analyzed. This study shows that the appropriate medical treatment prices for FVs, considering profits, were 1.22-4.26 times higher compared with prices under Japan's public health insurance plans. Furthermore, these prices were 1.31-4.26 times higher for outpatients with pharyngitis and external injury and 1.22-3.66 times higher for inpatients with appendicitis and femoral fractures. The price of pharyngitis treatment in 12 countries was USD 20.32-158.75 per patient for Japanese tourists, whereas FVs paid 60.24 dollars (1.13 times higher than Japan's public healthcare price) in Japan. This study shows it was appropriate to set the ideal price level for FVs higher than that for Japanese patients.

摘要

本研究提出了一种计算日本外国游客(FV)适当医疗价格水平的方法。从市场原则的角度分析医院管理成本和国外价格,以确定医疗价格。该研究包括两个阶段:初步调查和扩展调查,并辅以国际调查。选择了相对常见的疾病,通过三家医院的数据(涵盖24名门诊患者和4名住院患者)分析了医院治疗FV的成本。分析了三家保险公司为患有咽炎的日本游客支付的海外医疗机构服务费用。本研究表明,考虑到利润,FV的适当医疗价格比日本公共医疗保险计划下的价格高出1.22至4.26倍。此外,咽炎和外伤门诊患者的这些价格高出1.31至4.26倍,阑尾炎和股骨骨折住院患者的价格高出1.22至3.66倍。对于日本游客,12个国家咽炎治疗的价格为每位患者20.32美元至158.75美元,而FV在日本支付60.24美元(比日本公共医疗价格高1.13倍)。本研究表明,为FV设定高于日本患者的理想价格水平是合适的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/8199040/e367716f5ee8/ijerph-18-05837-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/8199040/9dfa43292c7e/ijerph-18-05837-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/8199040/ce6c0cd45e91/ijerph-18-05837-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/8199040/ffbc921dbfdc/ijerph-18-05837-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/8199040/edadb4f6d684/ijerph-18-05837-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/8199040/e367716f5ee8/ijerph-18-05837-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/8199040/9dfa43292c7e/ijerph-18-05837-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/8199040/ce6c0cd45e91/ijerph-18-05837-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/8199040/ffbc921dbfdc/ijerph-18-05837-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/8199040/edadb4f6d684/ijerph-18-05837-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da79/8199040/e367716f5ee8/ijerph-18-05837-g005.jpg

相似文献

1
Preliminary Examination of an Appropriate Price Calculation Method and Medical Treatment Costs for Foreign Visitors in Japan.日本外国游客适当价格计算方法及医疗费用的初步考察。
Int J Environ Res Public Health. 2021 May 29;18(11):5837. doi: 10.3390/ijerph18115837.
2
Price differences between Japan and the US for medical materials and how to reduce them.日本和美国在医疗材料方面的价格差异以及如何缩小这些差异。
Health Policy. 2007 Jun;82(1):71-7. doi: 10.1016/j.healthpol.2006.08.003. Epub 2006 Oct 6.
3
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.给编辑的信:重新思考抗精神病药物治疗的成本:2020 年土耳其使用的药物的平均成本。
Turk Psikiyatri Derg. 2022 Summer;33(2):146-148. doi: 10.5080/u26315.
4
Determinants of market prices for drugs under Japan's national health insurance.日本国民健康保险制度下药品市场价格的决定因素。
J Med Econ. 2021 Jan-Dec;24(1):1109-1114. doi: 10.1080/13696998.2021.1974259.
5
Current disparities in the prices of medical materials between Japan and the United States: further investigation of cardiovascular medical devices.日本与美国之间医疗材料价格的当前差异:心血管医疗设备的进一步调查
J Cardiol. 2007 Feb;49(2):77-81.
6
Prices and availability of pharmaceuticals: evidence from nine countries.药品价格与可及性:来自九个国家的证据
Health Aff (Millwood). 2003 Jul-Dec;Suppl Web Exclusives:W3-521-36. doi: 10.1377/hlthaff.w3.521.
7
Price disparity of percutaneous coronary intervention devices in Japan and the United States in 2006.2006年日本和美国经皮冠状动脉介入治疗器械的价格差异
Circ J. 2007 Jul;71(7):1128-30. doi: 10.1253/circj.71.1128.
8
The actual status of drug prices and adjustment factors for drug price calculation: an analysis of ultra-orphan drug development in Japan.药品价格的实际状况及药品价格计算的调整因素:日本超罕用药开发分析。
Orphanet J Rare Dis. 2022 Nov 8;17(1):408. doi: 10.1186/s13023-022-02526-z.
9
Hospital pricing: cost shifting and competition.医院定价:成本转嫁与竞争。
EBRI Issue Brief. 1993 May(137):1-17.
10
A comprehensive survey of cancer medicines prices, availability and affordability in Ghana.加纳癌症药物价格、可及性和可负担性的综合调查。
PLoS One. 2023 May 3;18(5):e0279817. doi: 10.1371/journal.pone.0279817. eCollection 2023.

引用本文的文献

1
Incidental diagnosis of Fabry disease by detecting mulberry bodies in a Bangladeshi male with infertility and residing in Japan: a case report highlighting clinical and economic challenges.在一名居住在日本的患有不育症的孟加拉男性中通过检测桑葚状小体偶然诊断出法布里病:一例凸显临床和经济挑战的病例报告
J Rural Med. 2025 Jul;20(3):233-237. doi: 10.2185/jrm.2024-050. Epub 2025 Jul 1.
2
Treatment of Latent Tuberculosis Infection in a Kawasaki Disease Patient Receiving Anti-Tumor Necrosis Factor Alpha (TNFα) Therapy.一名接受抗肿瘤坏死因子α(TNFα)治疗的川崎病患者的潜伏性结核感染治疗
Cureus. 2024 Sep 28;16(9):e70407. doi: 10.7759/cureus.70407. eCollection 2024 Sep.
3

本文引用的文献

1
How Procurement Judges The Value of Medical Technologies: A Review of Healthcare Tenders.采购如何评估医疗技术的价值:医疗招标回顾。
Int J Technol Assess Health Care. 2019 Jan;35(1):50-55. doi: 10.1017/S0266462318003756. Epub 2019 Feb 8.
2
Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies.中低收入国家成本效益分析阈值的使用和误用:成本效益分析研究中成本每残疾调整生命年的趋势。
Value Health. 2018 Jul;21(7):759-761. doi: 10.1016/j.jval.2017.12.016. Epub 2018 Feb 21.
3
An Evaluation of Clinical Economics and Cases of Cost-effectiveness.
Electrochemical Microneedles: Innovative Instruments in Health Care.
电化学微针:医疗保健领域的创新器械。
Biosensors (Basel). 2022 Sep 28;12(10):801. doi: 10.3390/bios12100801.
临床经济学与成本效益案例评估
Intern Med. 2018 May 1;57(9):1191-1200. doi: 10.2169/internalmedicine.9835-17. Epub 2017 Dec 27.
4
Consumer willingness-to-pay for packaging and contents in Asian countries.亚洲国家消费者对包装和内容物的支付意愿。
Waste Manag. 2017 Oct;68:724-731. doi: 10.1016/j.wasman.2017.06.042. Epub 2017 Jun 29.
5
Implications of new accounting rules for income taxes.新会计准则对所得税的影响。
Healthc Financ Manage. 1994 Feb;48(2):46, 48-9, 51 passim.
6
Hospital pricing: cost shifting and competition.医院定价:成本转嫁与竞争。
EBRI Issue Brief. 1993 May(137):1-17.
7
An overview of the development and refinement of the Resource-Based Relative Value Scale. The foundation for reform of U.S. physician payment.基于资源的相对价值量表的发展与完善概述。美国医生薪酬改革的基础。
Med Care. 1992 Nov;30(11 Suppl):NS1-12. doi: 10.1097/00005650-199211001-00001.